RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Isofol Medical AB (publ) Stock

Isofol Medical AB (publ) Net Income 2024

Isofol Medical AB (publ) Net Income

-8.97 M SEK

Ticker

ISOFOL.ST

ISIN

SE0009581051

WKN

A2DPV6

In 2024, Isofol Medical AB (publ)'s profit amounted to -8.97 M SEK, a -75.8% increase from the -37.07 M SEK profit recorded in the previous year.

The Isofol Medical AB (publ) Net Income history

YEARNET INCOME (undefined SEK)
2026e533.25
2025e374.11
2024e-8.97
2023-37.07
2022-159.79
2021-200.25
2020-188.99
2019-161.58
2018-83.13
2017-72.04
2016-64.95
2014-31.68
2013-33.73
2012-10.6

Isofol Medical AB (publ) Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Isofol Medical AB (publ), a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Isofol Medical AB (publ) from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Isofol Medical AB (publ)’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Isofol Medical AB (publ). Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Isofol Medical AB (publ)’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Isofol Medical AB (publ)’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Isofol Medical AB (publ)’s growth potential.

Isofol Medical AB (publ) Revenue, EBIT and net profit per share

DateIsofol Medical AB (publ) RevenueIsofol Medical AB (publ) EBITIsofol Medical AB (publ) Net Income
2026e3.33 B undefined490.85 M undefined533.25 M undefined
2025e1.33 B undefined352.05 M undefined374.11 M undefined
2024e70.7 M undefined-7.58 M undefined-8.97 M undefined
2023721,000 undefined-41.68 M undefined-37.07 M undefined
202212.8 M undefined-167.54 M undefined-159.79 M undefined
202122.41 M undefined-204.47 M undefined-200.25 M undefined
202037.12 M undefined-186.49 M undefined-188.99 M undefined
20190 undefined-167.8 M undefined-161.58 M undefined
20180 undefined-89.85 M undefined-83.13 M undefined
20170 undefined-72.59 M undefined-72.04 M undefined
20160 undefined-64.95 M undefined-64.95 M undefined
20140 undefined-31.86 M undefined-31.68 M undefined
20130 undefined-35.36 M undefined-33.73 M undefined
20120 undefined-10.53 M undefined-10.6 M undefined

Isofol Medical AB (publ) stock margins

The Isofol Medical AB (publ) margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Isofol Medical AB (publ). The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Isofol Medical AB (publ).

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Isofol Medical AB (publ)'s sales revenue. A higher gross margin percentage indicates that the Isofol Medical AB (publ) retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Isofol Medical AB (publ)'s earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Isofol Medical AB (publ)'s total revenue generated. When comparing the revenue margin year over year, investors can gauge the Isofol Medical AB (publ)'s growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Isofol Medical AB (publ). Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Isofol Medical AB (publ)'s financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Isofol Medical AB (publ) Margin History

Isofol Medical AB (publ) Gross marginIsofol Medical AB (publ) Profit marginIsofol Medical AB (publ) EBIT marginIsofol Medical AB (publ) Profit margin
2026e-4,773.23 %14.76 %16.04 %
2025e-4,773.23 %26.47 %28.13 %
2024e-4,773.23 %-10.71 %-12.69 %
2023-4,773.23 %-5,781.28 %-5,141.61 %
2022-1,023.02 %-1,309.24 %-1,248.68 %
2021-777.9 %-912.51 %-893.7 %
2020-437.55 %-502.42 %-509.15 %
2019-4,773.23 %0 %0 %
2018-4,773.23 %0 %0 %
2017-4,773.23 %0 %0 %
2016-4,773.23 %0 %0 %
2014-4,773.23 %0 %0 %
2013-4,773.23 %0 %0 %
2012-4,773.23 %0 %0 %

Isofol Medical AB (publ) Aktienanalyse

What does Isofol Medical AB (publ) do?

Isofol Medical AB (publ) is a Swedish company that was founded in 2006 and is listed on the Nasdaq Stockholm exchange. The company focuses on the development of medical solutions for a wide range of diseases, with a particular emphasis on cancer treatment. Isofol's main product is Modufolin, a proprietary technology that is an advancement of the well-known drug Folic Acid, commonly used in cancer therapy. Modufolin has a longer duration in the body, making it more effective in inhibiting tumor cell growth. Isofol also has a diagnostic division that specializes in developing tests for detecting Vitamin B12 levels in the body, which are crucial for identifying diseases such as dementia and anemia. Isofol Medical AB (publ) ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Isofol Medical AB (publ)'s Profit Margins

The profit margins of Isofol Medical AB (publ) represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Isofol Medical AB (publ)'s financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Isofol Medical AB (publ)'s profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Isofol Medical AB (publ)'s profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Isofol Medical AB (publ)’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Isofol Medical AB (publ) stock

How much profit has Isofol Medical AB (publ) made this year?

Isofol Medical AB (publ) has made -8.97 M SEK this year.

How has the profit developed compared to last year?

The profit has increased by -75.8% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Isofol Medical AB (publ) publish its earnings?

Isofol Medical AB (publ) publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Isofol Medical AB (publ)?

The profits of Isofol Medical AB (publ) are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Isofol Medical AB (publ)?

You can learn more about the earnings of Isofol Medical AB (publ) by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Isofol Medical AB (publ) pay?

Over the past 12 months, Isofol Medical AB (publ) paid a dividend of 0.76 SEK . This corresponds to a dividend yield of about 33.57 %. For the coming 12 months, Isofol Medical AB (publ) is expected to pay a dividend of 0.76 SEK.

What is the dividend yield of Isofol Medical AB (publ)?

The current dividend yield of Isofol Medical AB (publ) is 33.57 %.

When does Isofol Medical AB (publ) pay dividends?

Isofol Medical AB (publ) pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Isofol Medical AB (publ)?

Isofol Medical AB (publ) paid dividends every year for the past 0 years.

What is the dividend of Isofol Medical AB (publ)?

For the upcoming 12 months, dividends amounting to 0.76 SEK are expected. This corresponds to a dividend yield of 33.57 %.

In which sector is Isofol Medical AB (publ) located?

Isofol Medical AB (publ) is assigned to the 'Health' sector.

Wann musste ich die Aktien von Isofol Medical AB (publ) kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Isofol Medical AB (publ) from 2/20/2023 amounting to 0.755 SEK, you needed to have the stock in your portfolio before the ex-date on 2/14/2023.

When did Isofol Medical AB (publ) pay the last dividend?

The last dividend was paid out on 2/20/2023.

What was the dividend of Isofol Medical AB (publ) in the year 2023?

In the year 2023, Isofol Medical AB (publ) distributed 0 SEK as dividends.

In which currency does Isofol Medical AB (publ) pay out the dividend?

The dividends of Isofol Medical AB (publ) are distributed in SEK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Isofol Medical AB (publ)

Our stock analysis for Isofol Medical AB (publ) Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Isofol Medical AB (publ) Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.